Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials

Daniel R. Morales, Brian J. Lipworth, Bruce Guthrie, Catherine Miriam Jackson, Peter T. Donnan, Virginia Hernandez Santiago